Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. LFMD
LFMD logo

LFMD

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LFMD News

LifeMD Stock Soars After Strong Q4 Performance and Upgraded Rating

10h agoseekingalpha

LifeMD Reports Strong Q4 and Full Year 2025 Earnings Growth

23h agoYahoo Finance

LifeMD, Inc. Reports Strong Q4 2025 Earnings with Positive Outlook

1d agoseekingalpha

LifeMD Reports Q4 2025 Results Exceeding Expectations

1d agoseekingalpha

LifeMD Q4 Earnings Beat Expectations with Strong Guidance

1d agoseekingalpha

LifeMD Executives Allegedly Breached Fiduciary Duties

Jan 28 2026Globenewswire

Zentalis Pharmaceuticals (ZNTL) Surges 17.65% as Investors Renew Interest

Jan 12 2026NASDAQ.COM

Novo Nordisk Launches Wegovy Pill with 17% Average Weight Loss Efficacy

Jan 05 2026Benzinga

LifeMD Expands Collaboration with Novo Nordisk to Enhance Offerings

Jan 05 2026Yahoo Finance

LifeMD Launches Wegovy for Weight Management at $149/month

Jan 05 2026NASDAQ.COM

LifeMD Launches Wegovy Oral Medication at $149 Monthly Fee

Jan 05 2026Globenewswire

GH Research (GHRS) Stock Surges 22.36% Ahead of Key Update

Jan 05 2026NASDAQ.COM

Novo Nordisk and Eli Lilly Launch Weight-Loss Drugs Targeting $150 Billion Market

Dec 29 2025Newsfilter

LifeMD Declares $0.5546875 Cash Dividend for Preferred Stockholders

Dec 26 2025Globenewswire

LifeMD Declares $0.5546875 Cash Dividend for Preferred Stockholders

Dec 26 2025Newsfilter

Benzinga Market Update: Nvidia, Webull, Netflix, and Tech Stocks Experience Largest Sell-Off Since April

Nov 22 2025Benzinga